Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
investing
2
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alicia hager
alpha-1 antitrypsin
alphabet
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
arrowhead pharmaceuticals
axovant gene therapies
bacteriophage
biogen
biontech
biotech ipos
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
broad institute of harvard and mit
brook byers
cancer
cancer immunotherapy
charles chu
charles rice
chinook therapeutics
What
bio
2
×
crispr
2
×
alliance
available
based
big
biosciences
bristol
buy
calls
cas
changing
cheaper
color
days
develop
diagnostics
expects
faster
growing
hours
kudos
leaves
mammoth
myers’s
notifying
october
phone
rnai
roundup
rouse
scientists
set
shorter
slumber
things
time
tiny
today
wee
Language
unset
Current search:
investing
×
bio
×
crispr
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
